Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT06142760
Eligibility Criteria:
Inclusion Criteria:
* biopsy-proven cervical cancer including squamous-cell carcinoma, adenocarcinoma or adeno-squamous cell carcinoma
* FIGO stage IB, IIA, IIB, IIIA, IIIB, IIIC1
* indication and eligibility for definitive chemoradiotherapy including brachytherapy discussed in an interdisciplinary tumor board
* Karnofsky performance score ≥ 70%
* 18-80 years of age
* Capacity of the patient to consent to participation in the study
Exclusion Criteria:
* FIGO stage IIIC2 and IV
* Paraaortic lymphatic node metastases
* small cell neuroendocrine cancer, melanoma and other rare cancers of the cervix
* previous radiotherapy of the pelvic region
* previous total or partial hysterectomy
* neoadjuvant chemotherapy
* contraindications against performing contrast-enhanced MRI scans (pacemakers, other implants making MRI impossible, allergy to gadolinium (GD)-based contrast agent)
* claustrophobia
* pregnant or lactating women
* other primary malignancies within 5 years before except carcinoma in situ of the cervix and basal cell carcinoma of the skin
* patient is enrolled in another study, that could influence the outcome of the presented study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06142760
Study Brief:
Protocol Section:
NCT06142760